Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey
JCO Global Oncology · 2026
DOI: 10.1200/go-25-00414 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2026. Verfasst von Cibele Barbosa Carroll und 5 weiteren Autor:innen. Beteiligte Einrichtung: Carbone Cancer Center-University of Wisconsin Madison, Madison, WI. Hauptthemen laut MEDLINE: Survivorship, Neoplasms, Cancer Care Facilities, Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Cancer survivorship evolved over the past few years in developed countries although in developing countries, guidelines and evidence-based recommendations on survivorship care are still lacking. We sought to gather information on cancer survivorship practices in Brazil to identify assets and areas for improvement. METHODS Two surveys were developed regarding survivorship knowledge and the provision of services. Brazilian providers (physicians and nurses) and cancer center leaders received the surveys' invitation via WhatsApp groups of Brazilian oncology professionals. In addition, they were informed to share the study information with their networks (snowball sampling). The link to the surveys was advertised at Brazilian oncology conferences between August and December 2024. Descriptive statistics were used to summarize the results. RESULTS Between August 13 and December 17, 2024, 194 unique providers and 28 cancer center leaders responded to the online survey. Among providers, 70% considered a cancer survivor a patient who completed cancer treatment and has no evidence of disease. The majority (60%) reported never consulting a survivorship guideline. The most common tool used to support survivors was a treatment summary (52.1%). Among cancer center leaders, 32.1% reported that their institutions have survivorship programs. The most common services offered to cancer survivors include medical follow-up, nutrition, and psychology services (100%), whereas reproductive medicine and sexual therapy were offered by 7.7% of cancer centers. Although 28.6% of the cancer center leaders reported that nurses specialized in oncology participate in follow-up care of cancer survivors who completed curative treatment, 14.9% of providers responded that these nurses are involved in survivorship follow-up. CONCLUSION Cancer care providers and cancer centers from Brazil can benefit from culturally tailored survivorship guidelines to better address cancer survivors' needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Carbone Cancer Center-University of Wisconsin Madison, Madison, WI.
- Instituto Nacional do Câncer, Rio de Janeiro, Brazil.
- Hospital Santa Rita de Cássia, Vitória, Brazil.
- University of Wisconsin, School of Medicine and Public Health, Department of Medicine, Madison, WI.
ORCID-Profile: Cibele Barbosa Carroll, Juliana Ribeiro de Carvalho, Priyanka Pophali, Noelle K LoConte
Zitieren
APA
Barbosa Carroll, C., Ribeiro de Carvalho, J., Cardona Miranda Machado, A. L., Dittus, K., Pophali, P., & LoConte, N. K. (2026). Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey. JCO Global Oncology. https://doi.org/10.1200/go-25-00414
Vancouver
Barbosa Carroll C, Ribeiro de Carvalho J, Cardona Miranda Machado AL, Dittus K, Pophali P, LoConte NK. Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey. JCO Global Oncology. 2026. doi:10.1200/go-25-00414
BibTeX
@article{BarbosaCarroll2026,
author = {Barbosa Carroll, Cibele and Ribeiro de Carvalho, Juliana and Cardona Miranda Machado, Ana Luiza and Dittus, Kim and Pophali, Priyanka and LoConte, Noelle K},
title = {Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey},
journal = {JCO Global Oncology},
year = {2026},
doi = {10.1200/go-25-00414}
}
EUVIMED